01Principles and purposeThe professional or clinical skill and the decisions it supports.
Pregnancy prescribing requires a comparison between plausible courses of action. Continuing an effective medicine, changing treatment and leaving the condition untreated each carry consequences. The evidence may describe structural malformation, fetal growth, neonatal adaptation or maternal deterioration, and these outcomes should not be collapsed into a single safe or unsafe label. First establish what is actually being treated and how urgently treatment is needed. Then examine the exposure in the relevant time window, the quality and relevance of the evidence, and the alternatives available to this individual. A considered explanation should acknowledge uncertainty without suggesting that every exposure predicts harm.
Breastfeeding introduces a related but separate set of questions. Transfer into milk does not establish the infant’s absorbed dose, and infant exposure is not the only consideration when maternal treatment is necessary. The baby’s maturity, health and ability to clear a medicine matter, as do the maternal dose, route and duration. A short course in a mother feeding a healthy older infant can have a different risk profile from sustained treatment while feeding a premature newborn. The useful output is a plan: which medicine and formulation to use, whether feeding can continue, what to observe and who will reassess. Unnecessary interruption can itself create feeding difficulties and should not be treated as a consequence-free precaution.
Key points
- Assess the illness and the medicine together: untreated maternal disease can harm both the pregnant person and the fetus, so an automatic stop is not a complete risk assessment.
- Record gestational age, exact product, route, dose, timing and duration. Early developmental exposure, later fetal effects and effects near birth are different questions.
- Use current UKTIS/BUMPS, SPS, relevant NICE guidance and the exact SmPC. A restrictive product statement and specialist clinical guidance may answer different questions; document the reasoning for the actual decision.
- Paracetamol remains an appropriate choice for pain or fever in pregnancy when needed. Use the lowest effective oral dose for the shortest necessary time and assess persistent symptoms rather than substituting an NSAID casually.
- Avoid systemic NSAIDs from 20 weeks unless clinically required; they are contraindicated from 28 weeks. Specialist assessment may be needed after prolonged exposure because fetal renal and ductal effects are relevant.
- During breastfeeding, include infant gestational age at birth, current age, health, feeding pattern and exposure to other medicines. Advice for healthy term infants cannot automatically be extended to premature or unwell infants.
- Provide the medicine plan and the observations that should trigger help. Avoid blanket instructions to stop breastfeeding or discard milk without a medicine-specific assessment.
02Situations and prioritiesThe context, relevant information and actions that matter most.
Ask about prescription medicines, pharmacy purchases, supplements, topical products and medicines borrowed from others. Record whether the person has already taken the drug or is asking about a future course. A photograph of the package may resolve a combination product or strength. The date of each exposure can be more informative than the date of the positive pregnancy test.
Determine disease severity and the consequence of a gap in control. Stopping antiseizure, psychiatric or other essential treatment abruptly can create substantial harm. A person who reports a new pregnancy needs timely access to the relevant specialist plan, not an instruction to abandon every repeat medicine while waiting for a routine appointment.
For breastfeeding advice, ask gestational age at birth, chronological age, current weight, medical problems and whether feeding is exclusive or partial. Consider simultaneous prenatal exposure and medicines given directly to the baby. Prematurity, respiratory illness or poor feeding should lower the threshold for specialist advice and closer observation.
Severe headache with visual symptoms, significant abdominal pain, collapse, breathlessness or severe hypertension in pregnancy requires clinical assessment rather than a routine analgesic recommendation. Similarly, an unusually sleepy infant with poor feeding or breathing difficulty needs urgent assessment. The medicine history informs that assessment but does not replace evaluation of other causes.
03Assessment and interpretationHow to gather information, assess the situation and recognise uncertainty.
Consider the information, its meaning and its limitations before deciding what follows.
- 01
Gestational dating and exposure timeline - Why
- Relate a medicine course to the relevant pregnancy stage.
- Interpretation and limitations
- Use the best available gestational assessment and document uncertainty when dates are unclear. A several-day NSAID course at 25 weeks raises different issues from an isolated preconception dose. Refer targeted fetal monitoring decisions to the appropriate pregnancy or teratology service rather than inventing reassurance from a normal early scan.
- 02
Maternal clinical observations and organ function - Why
- Assess the condition and factors that change medicine handling.
- Interpretation and limitations
- Blood pressure, temperature, hydration, kidney function and liver assessment may be necessary according to the presentation. Pregnancy does not remove ordinary prescribing contraindications. A dehydrated patient with kidney injury needs a different analgesic and medicine review from a well person with a self-limiting headache.
- 03
Infant feeding, growth and clinical assessment - Why
- Detect clinically meaningful effects during maternal treatment.
- Interpretation and limitations
- Observation should be specific to the medicine and the baby. Poor feeding, unusual drowsiness, vomiting or diarrhoea may merit assessment, but their significance depends on severity and context. Do not ask a parent to monitor an inaccessible laboratory parameter at home without arranging a clinician to interpret it.
- 04
Current specialist medicine information - Why
- Resolve the actual pregnancy or breastfeeding prescribing question.
- Interpretation and limitations
- Consult a source that matches the formulation, route, exposure window and population. Distinguish human clinical evidence from theoretical concerns and product licensing wording. If advice differs, investigate why and document the chosen clinical rationale; a search result describing all pregnancy medicines generically cannot settle an individual exposure.
04Worked approachesCases with ordered reasoning, an action and a check of the outcome.
01Worked caseAssess an analgesic request at 25 weeksA 30-year-old at 25 weeks of pregnancy, weighing 68 kg with normal renal and liver function, requests ibuprofen for a mild headache. Blood pressure is 118/72 mmHg; she has no visual symptoms, fever, neurological features or existing analgesic exposure.+
- 1First confirm the supplied absence of warning features and assess whether the headache needs further investigation. The normal pressure is one reassuring input, but persistent, severe or changing symptoms would require reassessment rather than repeated symptomatic treatment.
- 2Identify the requested medicine as a systemic NSAID and place the exposure at 25 weeks. Current MHRA advice is to avoid use from 20 weeks unless clinically necessary; the request therefore needs an alternative analgesic discussion, not an unrestricted over-the-counter recommendation.
- 3For this otherwise suitable adult, choose paracetamol 500 mg to 1 g orally when required, at least 4 hours between doses, with no more than four doses and no more than 4 g in any 24 hours. Advise the lowest effective dose for the shortest needed course and check combination products before supplying it.
- 4Give the final action: use the agreed paracetamol regimen if needed, avoid self-starting ibuprofen and seek assessment if symptoms persist or warning features develop. Verify independently that the total daily paracetamol exposure includes all products and that she can explain the dose spacing and reason for reassessment.
02Exposure reviewRespond to an unplanned pregnancy on treatmentA person taking regular medication reports a newly confirmed pregnancy.+
- 1Collect the full list and precise exposure dates, assess the maternal condition and identify any medicine needing urgent specialist review. Explain that a positive pregnancy test calls for an organised review; it does not establish that fetal harm has occurred.
- 2Compare continuing, changing and stopping treatment using current medicine-specific pregnancy evidence and the risk of untreated illness. Arrange urgent specialist input for high-risk medicines and conditions, particularly when abrupt withdrawal could cause seizures or serious relapse.
- 3Agree the immediate prescription and any contraception, folate, monitoring or referral action that applies. If treatment is changed, give a precise transition plan and ensure that a gap or overlap does not occur through conflicting prescriptions.
- 4Document the discussion in language the patient can revisit, including uncertainty and the planned follow-up. Send the agreed medicine plan to the clinicians responsible for antenatal and disease-specific care so that advice remains coherent.
03LactationMake a medicine-specific breastfeeding planA breastfeeding parent requires a new medicine or reports a possible infant effect.+
- 1Clarify the maternal diagnosis and urgency, exact drug and route, proposed dose and duration, and any alternatives. Obtain the infant’s maturity, age, health and feeding pattern before applying recommendations written for healthy full-term infants.
- 2Use current specialist lactation advice to assess likely exposure and relevant adverse effects. For common mild pain, paracetamol is a preferred option; codeine should not be used during breastfeeding. More complex or premature-infant situations need individual specialist advice.
- 3Provide the selected regimen and observations that the parent can recognise. Explain who to contact for mild concerns and when poor feeding, unusual drowsiness or breathing problems require urgent help; avoid leaving the parent to interpret a vague instruction to watch the baby.
- 4Confirm that feeding and maternal treatment remain effective at follow-up. If interruption was specifically necessary, arrange support and a defined reassessment of resumption rather than allowing an indefinite change to arise from uncertainty.
05Relevant medicines and safetySpecific regimens and precautions when the skill involves prescribing.
Paracetamol for short-term pain or fever
For a suitable adult weighing at least 50 kg, 500 mg to 1 g orally as needed, at least 4 hours apart, no more than four doses and no more than 4 g in any 24 hours; use the lowest effective dose for the shortest necessary duration.Check all combination products. Lower weight, liver disease, malnutrition or significant renal impairment requires dose or interval review. Persistent pain or fever needs assessment; pregnancy does not justify exceeding the ordinary total dose limit.
Folic acid around conception
Usually 400 micrograms orally once daily before conception and through the first 12 weeks; selected higher-risk patients require a prescribed 5 mg orally once-daily regimen under current pregnancy guidance.A previous or family neural-tube defect, diabetes or certain medicines may require the higher dose. Confirm the individual criteria rather than equating every supplement or body-weight category with an automatic 5 mg indication.
Aspirin for eligible pre-eclampsia prevention
NICE recommends 75–150 mg orally once daily from 12 weeks until birth for appropriate high-risk pregnancies, using the agreed maternity prescription and follow-up plan.Assess allergy and bleeding concerns with the maternity team. This prescribed low-dose preventive use is distinct from self-treatment with analgesic-dose aspirin or other systemic NSAIDs; do not stop it because of a generic NSAID warning.
06Feedback, follow-up and evidenceReview outcomes, seek feedback and identify what to improve.
- After changing an essential maternal medicine, check disease control as well as potential adverse effects. A theoretically attractive replacement that fails to control the condition is not automatically a safer outcome for mother or fetus.
- Review advice when gestation advances, delivery approaches or feeding begins. A medicine-specific concern near birth may differ from its earlier developmental risk, and a pregnancy decision does not automatically answer the breastfeeding question.
- For lactation, agree practical infant observations and follow-up proportional to exposure and vulnerability. Healthy term-infant advice may need reconsideration after a new illness, poor weight gain or a change to a higher maternal dose.
- Update the medication record and communicate temporary and long-term decisions across primary care, maternity and relevant specialists. Conflicting advice should be resolved with the original reasoning available, rather than asking the patient to choose between unexplained instructions.
07Special situationsVariants, exceptions and circumstances that change the usual approach.
Exposure is not an outcome
A report that a drug can cause harm does not determine what happened in one pregnancy. Dose, timing and baseline risk matter. Explain what can be assessed now and what follow-up is justified without claiming that risk is either zero or inevitable.
Small milk transfer is one component
The infant’s ability to absorb and clear a medicine influences the clinical effect of milk exposure. Prematurity and illness can therefore change the plan even when the maternal prescription and measured milk concentration are unchanged.
Low-dose aspirin has a distinct purpose
Prescribed pre-eclampsia prevention should not be confused with analgesic NSAID use. The correct response to a broad safety warning is to identify the exact medicine, dose and indication, then apply the relevant obstetric guidance.
Shared decisions need usable language
Describe the expected benefit, the possible harm and the next action in terms the person can repeat. A technically accurate list of theoretical risks is less useful than a clear account of why a particular treatment and review plan fit their situation.
08Common pitfallsFrequent interpretation and management errors.
- 01
Advising immediate cessation of all regular medicines after a positive pregnancy test can destabilise serious maternal disease before an alternative plan exists.
- 02
Applying healthy term-infant breastfeeding recommendations to a premature newborn without further assessment overlooks clinically important differences in clearance and vulnerability.
- 03
Assuming that a medicine bought without a prescription is safe throughout pregnancy can miss gestation-specific harm from systemic NSAIDs.
- 04
Recommending routine expression and disposal of breast milk without a defined pharmacological reason can disrupt feeding while failing to answer the actual medicine question.